SuperworthGlobus Medical profit margin GMED
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- 17.0%
- Operating margin, 12 months
- 20.3%
- Net margin on a year earlier
- +3.4 pts
- Peer median
- 11.8%
Over the twelve months to Jun 30, 2026, Globus Medical kept 17.0% of its revenue as net profit, with an operating margin of 20.3% and a gross margin of 20.3%.
Five years earlier its net margin was 19.8%.
The median for 10 medical instruments and supplies stocks of a similar size is 11.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 18.3% | 16.3% | 16.3% |
| FY2024 | 4.1% | 6.6% | 6.6% |
| FY2023 | 7.8% | 8.5% | 49.2% |
| FY2022 | 18.6% | 22.3% | 74.2% |
| FY2021 | 15.6% | 17.9% | 75.0% |
| FY2020 | 13.0% | 14.1% | 72.4% |
| FY2019 | 19.8% | 21.9% | 77.1% |
| FY2018 | 21.9% | 17.7% | 77.6% |
| FY2017 | 16.9% | 25.4% | 76.3% |
| FY2016 | 18.5% | 27.3% | 76.1% |
| FY2015 | 20.7% | 31.6% | 75.7% |
| FY2014 | 19.5% | 29.2% | 76.6% |
| FY2013 | 15.8% | 23.4% | 76.9% |
| FY2012 | 19.1% | 29.7% | 80.5% |
| FY2011 | 18.3% | 29.4% | 79.2% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 17.0% | +3.4 pts | 20.3% | |
| Q1 FY26 | 18.9% | +11.5 pts | 17.2% | |
| Q4 FY25 | 18.3% | +14.2 pts | 16.3% | |
| Q3 FY25 | 15.3% | +11.6 pts | 13.4% | |
| Q2 FY25 | 13.6% | +11.8 pts | 10.7% | |
| Q1 FY25 | 7.4% | +3.9 pts | 10.2% | |
| Q4 FY24 | 4.1% | −3.7 pts | 6.6% | |
| Q3 FY24 | 3.7% | −9.2 pts | 4.7% | |
| Q2 FY24 | 1.8% | −16.8 pts | 3.0% | |
| Q1 FY24 | 3.5% | −15.3 pts | 4.5% | |
| Q4 FY23 | 7.8% | −10.8 pts | 8.5% | |
| Q3 FY23 | 12.9% | −2.7 pts | 14.4% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Globus Medical's size, closest first, today.
| Company | Profit margin |
|---|---|
| GMEDGlobus Medical | 17.0% |
| ALGNAlign Technology | 10.0% |
| PODDInsulet | 12.3% |
| COOCooper Companies | 13.5% |
| PENPenumbra | 10.7% |
| SOLVSolventum | 17.3% |
| MSAMSA Safety | 16.1% |
| MMSIMerit Medical Systems | 9.2% |
| HAEHaemonetics | 7.1% |
| VNTVontier | 11.3% |
| BMIBadger Meter | 14.3% |
| Peer median | 11.8% |
Where Globus Medical ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Globus Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.